HD
57
2
DVN
21
3
HPE
63
2
VMC
57
4
BF.B
33
2
DG
6
2
GE
67
2
STI
14
-17
LRCX
43
-2
VRSN
53
-4
WM
79
3
TDC
80
4
HBI
59
4
HP
48
3
MAS
58
2
EFX
38
2
FLR
58
3
NTAP
67
-3
CPB
30
6
MCD
52
2
HD
57
2
DVN
21
3
HPE
63
2
VMC
57
4
BF.B
33
2
DG
6
2
GE
67
2
STI
14
-17
LRCX
43
-2
VRSN
53
-4
WM
79
3
TDC
80
4
HBI
59
4
HP
48
3
MAS
58
2
EFX
38
2
FLR
58
3
NTAP
67
-3
CPB
30
6
MCD
52
2
Financhill
Back

ProShares Ultra Nasdaq Biotechnology Stock Predictions

Invest. Do Good. Get Rewarded. Just $0.26/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
37

BIB
ProShares Ultra Nasdaq Biotechnology

Last Price:
56.87
Seasonality Move:
16.48%

7 Day Trial

ALL ACCESS PASS

$ 7

Say this - unlock as much as $1,250 every Friday

Click here for full details.

ProShares Ultra Nasdaq Biotechnology Stock Forecast

  • Over the next 52 weeks, ProShares Ultra Nasdaq Biotechnology has on average historically risen by 24.3% based on the past 14 years of stock performance.
  • ProShares Ultra Nasdaq Biotechnology has risen higher in 10 of those 14 years over the subsequent 52-week period, corresponding to a historical accuracy of 71.43%
  • Is ProShares Ultra Nasdaq Biotechnology Stock Undervalued?
    The current ProShares Ultra Nasdaq Biotechnology [BIB] share price is $56.84. The Score for BIB is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • BIB is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will ProShares Ultra Nasdaq Biotechnology Stock Go Up Next Year?

  • Over the next 52 weeks, ProShares Ultra Nasdaq Biotechnology has on average historically risen by 24.3% based on the past 14 years of stock performance.

ProShares Ultra Nasdaq Biotechnology Stock Rating

Sell
37
ProShares Ultra Nasdaq Biotechnology (BIB) is a Sell

Is ProShares Ultra Nasdaq Biotechnology overpriced?

  • ProShares Ultra Nasdaq Biotechnology has risen higher in 10 of those 14 years over the subsequent 52-week period, corresponding to a historical accuracy of 71.43%

ProShares Ultra Nasdaq Biotechnology Stock Price History

Is BIB stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BIB is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Sector:
Type:
etf
Website:

52-Week Data

52-Week High:
69.56
52-Week Low:
42.84

Prediction Charts

Market Cap:
0
Price in USD:
56.84
Volume:
10.02K
Beta:
1.84

Technical Analysis

SMA50:
62.42
SMA100:
63.62
SMA200:
59.92
52-Wk Change:
30.4%

Stock Predictions

  • Is ProShares Ultra Nasdaq Biotechnology stock public?
    Yes, ProShares Ultra Nasdaq Biotechnology is a publicly traded company.
  • What is the ProShares Ultra Nasdaq Biotechnology stock quote today?
    The ProShares Ultra Nasdaq Biotechnology stock price is 56.84 USD today.
  • How to buy ProShares Ultra Nasdaq Biotechnology stock online?
    You can buy ProShares Ultra Nasdaq Biotechnology shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-5 61.16 63.13 63.13 60.95
Nov-6 65.00 64.31 65.00 63.50
Nov-7 64.72 65.98 66.17 64.72
Nov-8 65.20 66.86 67.00 65.20
Nov-11 67.18 66.34 68.00 66.20
Nov-12 65.15 62.76 65.76 62.69
Nov-13 62.84 61.75 64.04 61.73
Nov-14 60.97 58.97 61.15 58.68
Nov-15 58.00 53.66 58.00 53.50
Nov-18 53.66 53.40 53.67 52.79
Nov-19 52.52 53.52 53.71 52.19
Nov-20 53.80 54.31 54.44 53.33
Nov-21 54.39 55.10 55.44 53.42
Nov-22 55.19 56.84 57.24 55.19

ProShares Ultra Nasdaq Biotechnology Earnings

Data Unavailable

ProShares Ultra Nasdaq Biotechnology Forecast Revenue Growth

Data Unavailable

* ProShares Ultra Nasdaq Biotechnology stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.